Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Advent France Biotechnology Launches its Second Fund with a First Close at €86M ($102M)
Advent France Biotechnology (AFB), an AMF-regulated investment company dedicated to life sciences, today announces the […]
Nanoform Receives Funding to Solve Challenges for Global Health
Nanoform, an innovative nanoparticle medicine enabling company, announces that Proof of Concept studies will be […]
Vensana Capital Raises $325 Million and Expands Team to Back Transformative Medical Technology Innovations
Vensana Capital today announced the closing of its second fund, Vensana Capital II, with $325 million […]
Envisagenics Raises Series A Financing to Scale its AI-powered RNA Splicing Drug Discovery Platform
Envisagenics, an Artificial Intelligence-driven biotechnology company focused on the discovery and development of novel RNA […]
Prime Therapeutics and Pear Therapeutics Announce First Comprehensive Value-based Agreement for Prescription Digital Therapeutics reSET® and reSET-O® for the Treatment of Substance and Opioid Use Disorders
More than 20 million Americans struggle with drug addiction while only 10-20% receive treatment. Prime Therapeutics […]
FUJIFILM Irvine Scientific Begins Customer Qualification of European Manufacturing Facility
FUJIFILM Irvine Scientific, Inc., today announced that it completed construction and started the commissioning phase of its […]
Hyperfine Announces Plans for Global Expansion Starting with Launches in the United Kingdom and Pakistan
Hyperfine, Inc., creator of the first FDA-cleared portable magnetic resonance imaging (MRI) device, Swoop™, today […]
Cartesian Therapeutics Strengthens Leadership Team With Hire of Miloš Miljković, M.D., as Chief Medical Officer
Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company pioneering RNA cell therapy in and beyond […]
Avacta Group Achievement of Pre-clinical Development Milestone in LG Chem Life Sciences Partnership
Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and […]
Top Pharmaceutical Companies and CROs Rely on Vivalink for Real-World Patient Data in Decentralized Clinical Trials
Due to limitations necessitated by COVID-19, clinical trials have undergone a transformation. In tandem with […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more